BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 15453351)

  • 1. [Clinicopathological study of juvenile hepatocellular carcinoma with hepatitis B virus infection].
    Kitagawa S; Nakanuma Y; Kaizaki Y
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():381-6. PubMed ID: 15453351
    [No Abstract]   [Full Text] [Related]  

  • 2. [Explore the relationship between HBV genotypes and differentiation of hepatocellular carcinoma].
    Zeng DB; Lu SC; Lai W; Dai J; Wu JS
    Zhonghua Gan Zang Bing Za Zhi; 2009 Aug; 17(8):622-3. PubMed ID: 19719924
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinico-cytopathological spectrum of hepatocellular carcinoma, its correlation with serum alpha-fetoprotein level, and hepatitis B and C viral markers.
    Radhika NS; Duseja A; Rajwanshi A; Gupta SK; Sehgal S; Suri S; Chawla Y
    Trop Gastroenterol; 2004; 25(3):116-20. PubMed ID: 15682657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
    J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history of chronic hepatitis B REVEALed.
    Chen CJ; Yang HI
    J Gastroenterol Hepatol; 2011 Apr; 26(4):628-38. PubMed ID: 21323729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics and surgical outcome in hepatocellular carcinoma without hepatitis B virus surface antigen or hepatitis C virus antibody.
    Tanaka K; Shimada H; Matsuo K; Nagano Y; Endo I; Togo S
    Ann Surg Oncol; 2007 Mar; 14(3):1170-81. PubMed ID: 17195904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical characteristics of hepatocellular carcinoma in patients with antibody to hepatitis C virus].
    Nagoshi S; Fujiwara K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):615-8. PubMed ID: 15359871
    [No Abstract]   [Full Text] [Related]  

  • 8. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
    Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
    J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A prospective study of the relationship between serum hepatitis B virus DNA and the risk of primary liver cancer].
    Chen QY; Dong BQ; Yang JY; Wei SC; Fang KX; Wang XY; Fang ZL
    Zhonghua Gan Zang Bing Za Zhi; 2009 Dec; 17(12):930-4. PubMed ID: 20038336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A clinicopathological study of juvenile hepatocellular carcinoma with hepatitis B virus antigen].
    Toyosaka A; Oriyama T; Okamoto E
    Nihon Rinsho; 1995 Oct; 53 Suppl(Pt 2):704-12. PubMed ID: 12442471
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum alphafoetoprotein, hepatitis B virus infection and primary hepatocellular carcinoma in Nigerians.
    Ola SO; Olubuyide IO; Ayoola EA
    East Afr Med J; 1994 Dec; 71(12):782-3. PubMed ID: 7535684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Etiology of hepatocellular carcinomas in Madagascar: results of a study in Antananarivo from October 1995 to October 1996].
    Zeller HG; Rakotonirina J; Morel B; Pécarrère JL; Lapprand M
    Arch Inst Pasteur Madagascar; 1996; 63(1-2):62-6. PubMed ID: 12463021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of hepatitis virus infection in hepatocellular carcinoma patients receiving surgical operation in China and Japan].
    Yuan P; Tang W; Wen J; Li QM; Luo H; Liang BH; Zheng QM; Wei L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2005 Sep; 39(5):332-4. PubMed ID: 16266545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma.
    Suga M; Senota A; Arima K; Kodama T; Ikuta S; Sakamoto H; Ohe Y; Sugai S; Yachi A
    Hepatogastroenterology; 1994 Oct; 41(5):438-41. PubMed ID: 7531667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geographic variation in viral load among hepatitis B carriers with differing risks of hepatocellular carcinoma.
    Evans AA; O'Connell AP; Pugh JC; Mason WS; Shen FM; Chen GC; Lin WY; Dia A; M'Boup S; Dramé B; London WT
    Cancer Epidemiol Biomarkers Prev; 1998 Jul; 7(7):559-65. PubMed ID: 9681522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y; Sato M; Saito Y; Karube M; Doy M; Shoda J; Abei M; Tanaka N; Hadama T; Kinoshita M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):379-89. PubMed ID: 10606185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
    Chen JD; Yang HI; Iloeje UH; You SL; Lu SN; Wang LY; Su J; Sun CA; Liaw YF; Chen CJ;
    Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
    Ozer B; Serin E; Yilmaz U; Gümürdülü Y; Saygili OB; Kayaselçuk F; Boyacioğlu S
    Turk J Gastroenterol; 2003 Jun; 14(2):85-90. PubMed ID: 14614632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing infection-associated cancer: from bench to hillside.
    Goedert JJ
    J Natl Cancer Inst; 2005 Feb; 97(4):245-6. PubMed ID: 15713953
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatocellular carcinoma in the Philippines: a clinicopathological study of 150 cases.
    Irie H; Mori W; Dalmacio-Cruz AE; Guirnella EA; Zamuco JT
    Jpn J Cancer Res; 1985 Apr; 76(4):297-300. PubMed ID: 2989060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.